Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer

Cancer Res. 1994 Apr 15;54(8):2060-3.


The loss of DNA sequences on chromosomal bands 9p21-22 has been documented in a variety of malignancies including leukemias, gliomas, lung cancers, and melanomas. Because of the high incidence of monosomy 9 detected by both cytogenetics and loss of heterozygosity studies in bladder cancer, we examined seven bladder cancer cell lines for deletions in this region. Using seven DNA probes that span the region of 9p21-22 as well as a functional assay for methylthioadenosine phosphorylase (MTAP), which maps to 9p21, we found four cell lines that had small homozygous deletions. These deletions map centromeric to the interferon (IFN) gene cluster and telomeric to D9S171. Only one of the cell lines with deletions had a cytogenetically evident lesion in this chromosomal region. Preliminary loss of heterozygosity studies with 10 primary bladder cancer specimens using 10 markers spanning chromosome 9 revealed loss of heterozygosity at the IFN locus with retention of heterozygosity with more centromeric 9p markers and all informative 9q markers in the tumor of one patient. These data suggest that loss of a tumor suppressor gene on 9p21-22, which may represent a general pathway of oncogenesis, is important in bladder cancer development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Southern
  • Cell Line
  • Chromosome Banding
  • Chromosome Deletion*
  • Chromosome Mapping
  • Chromosomes, Human, Pair 9*
  • DNA, Neoplasm / analysis
  • DNA, Neoplasm / genetics
  • Genetic Markers
  • Homozygote
  • Humans
  • Interferons / genetics
  • Multigene Family
  • Polymerase Chain Reaction
  • Purine-Nucleoside Phosphorylase / genetics
  • Restriction Mapping
  • Telomere
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / genetics*


  • DNA, Neoplasm
  • Genetic Markers
  • Interferons
  • Purine-Nucleoside Phosphorylase
  • 5'-methylthioadenosine phosphorylase